CIK 0001815776 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
LENZ Therapeutics, Inc.
Sign in to watch- Ticker
- LENZ
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 844867570
- Phone
- 858-925-7000
- Business address
- 201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH, CA, 92075
- Former names
- Graphite Bio, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $9,134,778
- in 1 filing
Net −$9,134,778. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-11 | Gutry Phil CHIEF BUSINESS OFFICER | Purchase | +5,000 | $4.01 | $20K | 299,941 |
| 2022-04-01 | Young Alethia Chief Financial Officer | Grant or award · Stock Option (right to buy) | +350,000 | 350,000 | ||
| 2022-02-16 | Lehrer-Graiwer Joshua PRESIDENT AND CEO | Grant or award · Stock Option (right to buy) | +650,000 | 650,000 | ||
| 2022-02-16 | Gutry Phil CHIEF BUSINESS OFFICER | Grant or award · Stock Option (right to buy) | +115,000 | 115,000 | ||
| 2022-01-24 | Samsara BioCapital, L.P. 10% owner | Purchase | +23,000 | $8.70 | $200K | 8,034,850 |
| 2022-01-21 | Samsara BioCapital, L.P. 10% owner | Purchase | +100,000 | $8.99 | $899K | 8,011,850 |
| 2022-01-20 | Samsara BioCapital, L.P. 10% owner | Purchase | +43,105 | $8.92 | $384K | 7,911,850 |
| 2022-01-19 | Samsara BioCapital, L.P. 10% owner | Purchase | +54,565 | $9.24 | $504K | 7,868,745 |
| 2021-12-15 | Samsara BioCapital, L.P. 10% owner | Purchase | +22,329 | $10.19 | $228K | 7,814,180 |
| 2021-11-22 | Samsara BioCapital, L.P. 10% owner | Purchase | +201,685 | $10.15 | $2.0M | 7,791,851 |
| 2021-10-15 | Samsara BioCapital, L.P. 10% owner | Purchase | +2,300 | $12.49 | $29K | 7,590,166 |
| 2021-10-14 | Samsara BioCapital, L.P. 10% owner | Purchase | +3,100 | $12.50 | $39K | 7,587,866 |
| 2021-10-13 | Samsara BioCapital, L.P. 10% owner | Purchase | +45,400 | $13.22 | $600K | 7,584,766 |
| 2021-10-08 | Samsara BioCapital, L.P. 10% owner | Purchase | +75,000 | $13.12 | $984K | 7,539,366 |
| 2021-10-07 | Samsara BioCapital, L.P. 10% owner | Purchase | +9,021 | $14.94 | $135K | 7,464,366 |
| 2021-10-06 | Samsara BioCapital, L.P. 10% owner | Purchase | +61,475 | $13.83 | $850K | 7,455,345 |
| 2021-06-29 | Samsara BioCapital, L.P. 10% owner | Conversion | +6,167,763 | 6,167,763 | ||
| 2021-06-29 | Samsara BioCapital, L.P. 10% owner | Conversion | +741,107 | 6,908,870 | ||
| 2021-06-29 | Samsara BioCapital, L.P. 10% owner | Conversion | +22,753 | 22,753 | ||
| 2021-06-29 | Samsara BioCapital, L.P. 10% owner | Purchase | +485,000 | $17.00 | $8.2M | 7,393,870 |
Page 8 of 11 · 217 trades